Testing effectiveness (Phase 2)Enrolling By InvitationNCT07393373
What this trial is testing
Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia
Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 135